Is there any difference between Eastern and Western clinical practice guidelines in management of gastric cancer?
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study compares Eastern and Western gastric cancer (GC) clinical guidelines, finding shared practices in diagnosis and care but notable differences in treatment strategies and novel therapies. These variations highlight regional healthcare system and research focus diversity.
Area Of Science
- Oncology
- Gastroenterology
- Clinical Guideline Analysis
Background
- Gastric cancer (GC) is a leading cause of cancer mortality globally.
- Management strategies for GC may vary significantly across different countries.
- Investigating these international differences is crucial for optimizing patient care.
Purpose Of The Study
- To compare and contrast clinical practice guidelines for gastric cancer management from Eastern and Western regions.
- To identify commonalities and divergences in diagnostic, therapeutic, and supportive care recommendations.
Main Methods
- A systematic review of prominent GC clinical guidelines was conducted.
- Guidelines included those from the Korean GC Association (KGCA), Japanese GC Association (JGCA), National Comprehensive Cancer Network (NCCN), European Society for Medical Oncology (ESMO), British Society of Gastroenterology (BSG), and NICE.
- Guideline content was categorized and analyzed across eight key areas.
Main Results
- Common recommendations across Eastern (KGCA, JGCA) and Western (NCCN, ESMO, BSG, NICE) guidelines include thorough diagnosis, personalized treatment, and palliative care.
- Key differences were observed in specific treatment regimens, adoption of advanced therapies like immunotherapy, and use of techniques such as hyperthermic intraperitoneal chemotherapy (HIPEC).
Conclusions
- While core principles of GC management are shared, significant regional variations exist in treatment approaches.
- These disparities reflect differences in clinical environments, research priorities, and healthcare infrastructures.
- Further research may elucidate optimal strategies based on these diverse practices.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Vagotomy: This procedure aims to reduce gastric acid secretion by cutting a portion of the vagus nerve. While effective, its frequency has declined due to the availability of effective acid-suppressing medications. It may be performed with or...
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...